Search

Joshua D Andersen

from Kearns, UT
Age ~30
Get Report
Also known as:
Joshua D Anderson
Phone and address:
5002 S Heath Ave, Salt Lake City, UT 84118
Related to:
Stephen M AndersonMagdalene F Anderson, 70Ann AndersenKathy AndersenTerry A Cobb, 55Steven W Andersen, 35Thelma Ann Andersen, 85Cheryl L Donaldson, 68Terry D AndersenBuddy AndersenEric Andersen, 60Ut CobbBrent Cobb, 62Robert D AndersonCraig R Cobb, 64
Connected to:
Bernt A Andersen, 92Bjarke AndersenBoyd E Andersen, 81Bret A Andersen, 60Cali N AndersenCarl E Andersen, 60Cynthia M Andersen, 54Damian C Andersen, 45Darnel M Andersen, 63Doug Andersen

Joshua Andersen Phones & Addresses

  • 5002 S Heath Ave, Salt Lake Cty, UT 84118
  • Kearns, UT
  • Marble Falls, TX

Professional Records

License Records

Joshua Davenport Andersen

Address:
Salt Lake City, UT
License #:
8088056-1702 - Expired
Category:
Pharmacy
Issued Date:
Sep 9, 2011
Expiration Date:
Sep 9, 2016
Type:
Pharmacy Intern

Joshua J Andersen

License #:
8730 - Active
Category:
Water Operator
Issued Date:
Jul 29, 2013
Effective Date:
Jul 29, 2013
Expiration Date:
Dec 31, 2017
Type:
Grade VI Water Operator

Resumes

Resumes

Joshua Andersen Photo 1

Roseman University Of Health Sciences - Pharmacy Student

View page
Location:
Greater Salt Lake City Area
Industry:
Pharmaceuticals
Joshua Andersen Photo 2

Joshua Andersen

View page
Location:
Greater Salt Lake City Area
Industry:
Computer Games

Publications

Us Patents

Cell Cycle Arrest And Apoptosis

View page
US Patent:
7973018, Jul 5, 2011
Filed:
Oct 21, 2004
Appl. No.:
11/665416
Inventors:
Vicente Planelles - Salt Lake City UT, US
Joshua L. Andersen - Sandy UT, US
Erik Zimmerman - Salt Lake City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 48/00
A61K 35/00
US Classification:
514 44, 424 931
Abstract:
The HIV-1 accessory gene vpr encodes a conserved 96-amino acid protein that is necessary and sufficient for the HIV-1-induced block of cellular proliferation and induction of apoptosis. Expression of vpr in CD4 lymphocytes results in G2 arrest, followed by apoptosis. ATR, as a cellular factor that mediates Vpr-induced cell cycle arrest, is required for activation of the Breast Cancer-Associated Protein-1 (BRCA1). In addition, the Growth Arrest and DNA Damage protein (GADD45) is upregulated by Vpr in an ATR-dependent manner. Posttranscriptional silencing of either ATR or GADD45 leads to nearly complete suppression of the pro-apoptotic and/or cell cycle arrest effect of Vpr.

Cell Cycle Arrest And Apoptosis

View page
US Patent:
20120122770, May 17, 2012
Filed:
Jul 4, 2011
Appl. No.:
13/175912
Inventors:
Vicente Planelles - Salt Lake City UT, US
Joshua L. Andersen - Sandy UT, US
Erik Zimmerman - Salt Lake City UT, US
International Classification:
A61K 38/16
A61P 43/00
C40B 30/04
A61P 3/04
C07K 19/00
C12N 5/071
US Classification:
514 48, 530350, 514 189, 514 11, 435375, 506 9
Abstract:
The HIV-1 accessory gene vpr encodes a conserved 96-amino acid protein that is necessary and sufficient for the HIV-1-induced block of cellular proliferation and induction of apoptosis. Expression of vpr in CD4.sup.+ lymphocytes results in G2 arrest, followed by apoptosis. ATR, as a cellular factor that mediates Vpr-induced cell cycle arrest, is required for activation of the Breast Cancer-Associated Protein-1 (BRCA1). In addition, the Growth Arrest and DNA Damage protein (GADD45) is upregulated by Vpr in an ATR-dependent manner. Posttranscriptional silencing of either ATR or GADD45 leads to nearly complete suppression of the pro-apoptotic and/or cell cycle arrest effect of Vpr.
Control profile
Joshua D Andersen from Kearns, UT, age ~30 Get Report